Skip to main content
. 2023 Sep 11;35(1):e4. doi: 10.3802/jgo.2024.35.e4

Table 2. Surgical characteristics of 129 patients undergoing pelvic exenteration.

Surgical characteristics Values
Surgical approach
Open abdominal 100 (77.5)
Laparoscopy 12 (9.3)
Robotic 17 (13.2)
Extent of surgery
Anterior pelvic exenteration 63 (48.8)
Posterior pelvic exenteration 10 (7.8)
Total pelvic exenteration 56 (43.4)
Operative time (min) 540 (100–900)
<540 54 (41.9)
≥540 75 (58.1)
Surgical intent
Curative 93 (72.1)
Palliative (carcinosis, N+) 36 (27.9)
Carcinosis
Yes 14 (10.9)
No 115 (89.1)
Vulvectomy
Yes 9 (7)
No 120 (93)
Loop diverting ileostomy
Yes 8 (6.2)
No 121 (93.8)
Side wall
Yes 33 (25.6)
No 96 (74.4)
Colpectomy
Partial 31 (24)
Total 98 (76)
Pelvic floor reconstruction
Yes 4 (3.1)
No 125 (96.9)
Lymph node dissection
Yes 81 (62.8)
No 48 (37.2)
Positive node (n=81 total lymphadenectomy)
Yes 25 (30.9)
No 56 (69.1)
Length of stay (days) 14 (6–150)
<14 days 53 (41.1)
≥14 days 72 (55.8)
Unknown 4 (3.1)
Estimated blood loss (mL) 700 (100–3,500)
<700 31 (24.0)
≥700 36 (27.9)
Unknown 62 (48.1)
Tumor dimension (mm) 40 (0–150)
<40 45 (34.6)
≥40 56 (43.1)
Unknown 29 (22.3)

Values are presented as number of patients (%) or median (range).